Jubilant Pharmova Share Price

₹ 949.90

+₹26.10 (2.83%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: JUBLPHARMA
|
Pharmaceuticals

Jubilant Pharmova Share Price Today

As of 2 Nov 2026, Jubilant Pharmova share price is ₹949.90. The stock opened at ₹925.00, compared to its previous close of ₹923.80. During today's trading session, Jubilant Pharmova share price moved in the range of ₹919.00 to ₹949.90, with an average price of ₹934.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹786.05 and a high of ₹1,183.00. On the performance front, Jubilant Pharmova share price has declined by 0.30% over the last six months and is down 17.40% on a year-on-year basis.

Share price over the last 1 day rose from 927.55 to 949.90, ranging between 920.50 and 949.90.
₹919.00
2.83% up today
₹949.90
1D LOW
1D HIGH

Jubilant Pharmova Stock Insights

Latest Earning
Op Profit TrendDown by 50.91% QoQ
Latest Earning
Net Profit TrendDown by 52.72% QoQ
Latest Earning
Revenue TrendUp by 14.46% YoY
Stock Performance
OutperformingBeat Nifty by 4.25 % in last 3 month
Shareholding Pattern
PromoterPromoter increased stake by 0.01%
Shareholding Pattern
DIIDII decreased stake by 68.57%
Shareholding Pattern
FIIFII decreased stake by 3.16%
Technical Indicators
MACD CrossThe MACD line crossed above the signal line on 1 Day interval.
Jubilant Pharmova stock performance
Open₹925.00
High₹949.90
Low₹919.00
Prev. close₹923.80
Jubilant Pharmova trading activity
Volume1,48,076
Average traded price₹933.65
Last traded time03:29:56 02 Nov
Last traded quantity12
Circuit
L
H
₹739.05
₹1,108.55
52-week
L
H
₹786.05
₹1,183.00
Mkt Cap Cr
14,730.47
P/E
41.92
P/B
2.08
ROA
2.26%
ROE
5.62%
ROCE
6.41%
Quick Ratio
1.13
EV/EBITDA
13.84

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Jubilant Pharmo has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Jubilant Pharmo appears overvalued compared to its peers
Earnings: 2 out of 5, Poor
Earnings
Poor
Jubilant Pharmo earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Jubilant Pharmova Company Background

ISIN
INE700A01033
Sector Market Cap
₹ 14,730.47 Cr

Jubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company’s segments include Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation-Sterile Injectables, Generics, Contract Research, Development and Manufacturing Organisation, Proprietary Novel Drugs, and Management Services. The Radiopharma segment comprises radiopharmaceuticals, including radio pharmacies. The Contract Development and Manufacturing Organisation-Sterile Injectables segment includes contract development and manufacturing organisation-sterile injectables products. The Generics segment includes solid dosage formulations. The Contract Research, Development and Manufacturing Organisation segment includes drug discovery services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment includes patient-focused biopharmaceutical businesses working to address unmet medical needs in oncology and autoimmune diseases.

Jubilant Pharmova Financial Highlights

  • Revenue: Jubilant Pharmova reported revenue of ₹8,345.60 crore in FY26 vs ₹7,291.30 crore in FY25. It showed an increase of 14.46% on a yearly basis.
  • Operating Profit: Jubilant Pharmova reported an operating profit of ₹614.10 crore in FY26 vs ₹980.60 crore in FY25. It showed a decrease of 37.38% on a year-on-year basis.
  • Net Profit: Jubilant Pharmova reported a net profit of ₹397.50 crore in FY26 vs ₹836.30 crore in FY25. It showed a decrease of 52.47% on a yearly basis.

Jubilant Pharmova Quarterly Result Highlights

  • Jubilant Pharmova reported revenue of ₹2,249.30 crore in Jun 2026, compared with ₹2,313.70 crore in Mar 2026, representing a decrease of 2.78% on a quarter-on-quarter (QoQ) basis.
  • Jubilant Pharmova reported an operating profit of ₹86.40 crore in Jun 2026, compared with ₹176.00 crore in Mar 2026, representing a decrease of 50.91% on a quarter-on-quarter (QoQ) basis.
  • Jubilant Pharmova reported a profit of ₹56.40 crore in Jun 2026, compared with ₹119.30 crore in Mar 2026, reflecting a decrease of 52.72% on a QoQ basis.
  • The earnings per share (EPS) of Jubilant Pharmova stood at ₹25.15 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
47.68%
FII
15.37%
Other DII
1.07%
Retail and other
26.46%
Mutual funds
9.42%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202515.96%
Mar 202615.90%
Jun 202615.87%
Sep 202615.37%

Jubilant Pharmova Investment Returns

1 day
-2.35%
1 week
-1.55%
1 month
-10.21%
1 year
-17.40%
3 years
+142.37%
5 years
+54.95%

Jubilant Pharmova Share Price History

Jubilant Pharmova share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹946.00 / ₹923.80
-2.35%
29 Oct 26
₹943.90 / ₹946.00
+0.22%
28 Oct 26
₹953.30 / ₹943.90
-1.66%
27 Oct 26
₹939.80 / ₹959.80
+2.43%
Show more

Jubilant Pharmova Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹8,279.60₹7,234.50₹6,702.90₹6,281.70
Other Income₹66.00₹56.80₹68.70₹38.30
Total Revenue₹8,345.60₹7,291.30₹6,771.60₹6,320.00
Total Expenses₹7,672.00₹6,669.70₹6,456.30₹6,247.70
Profit Before Tax₹614.10₹980.60₹170.50₹27.80
Tax₹216.60₹144.30₹97.80₹92.70
Profit After Tax₹397.50₹836.30₹72.70-₹64.90
EPS - Basic₹25.15₹52.99₹4.87-₹3.83
EPS - Diluted₹25.08₹52.85₹4.86-₹3.83

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹614.10₹980.60₹170.50₹27.80
Income before WC changes₹1,296.80₹1,198.70₹925.90₹810.70
Change in Assets-₹149.60₹73.50₹197.00₹118.00
Change in Liabilities₹289.00₹38.30₹56.10-₹63.70
Change in WC₹139.40₹111.80₹253.10₹54.30
Cash flow from Operations₹1,226.80₹1,072.10₹971.30₹660.70
Cash flow from Investing-₹1,260.00₹487.70-₹607.90-₹544.40
Cash flow from Financing₹94.90-₹1,452.70-₹432.50-₹156.70
Total Cash Flow₹178.80₹131.90-₹57.50₹30.10
Cash (Start of the year)₹1,088.30₹956.40₹1,013.90₹983.80
Cash (End of the year)₹1,267.10₹1,088.30₹956.40₹1,013.90

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹11,413.40₹9,179.20₹7,672.40₹7,394.30
Current Assets₹4,109.30₹3,577.20₹3,876.10₹3,762.40
Total Assets₹15,522.70₹12,756.40₹11,548.50₹11,156.70
Current Liabilities₹2,538.90₹2,164.60₹1,889.00₹1,772.40
Net Current Asset₹1,570.40₹1,412.60₹1,987.10₹1,990.00
Non-Current Liabilities₹5,888.20₹4,353.20₹4,238.40₹3,992.50
Equity Capital₹7,095.60₹6,238.60₹5,421.10₹5,391.80
Total Equity & Liabilities₹15,522.70₹12,756.40₹11,548.50₹11,156.70

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹263.50₹231.40₹784.70₹810.10
Other Income₹2.40₹20.20₹103.40₹137.90
Total Revenue₹265.90₹251.60₹888.10₹948.00
Total Expenses₹228.00₹210.20₹846.40₹868.70
Profit Before Tax₹29.20₹41.40₹41.70₹79.30
Tax₹9.30₹19.20₹10.10₹29.40
Profit After Tax₹19.90₹22.20₹31.60₹49.90
EPS - Basic₹3.97₹1.21₹1.99₹3.13
EPS - Diluted₹3.97₹1.21₹1.99₹3.13

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹33.50₹37.60₹41.70₹79.30
Income before WC changes₹76.30₹116.80₹89.90₹44.10
Change in Assets₹24.50₹24.30₹71.50-₹55.90
Change in Liabilities-₹1.40₹7.00-₹6.00-₹35.90
Change in WC₹23.10₹31.30₹65.50-₹91.80
Cash flow from Operations₹93.60₹135.60₹143.20-₹65.10
Cash flow from Investing₹43.60-₹2.30-₹40.30₹31.10
Cash flow from Financing-₹129.90-₹156.80-₹77.80₹22.50
Total Cash Flow₹7.30-₹23.50₹25.10-₹11.50
Cash (Start of the year)₹12.60₹36.10₹11.00₹22.50
Cash (End of the year)₹10.30₹12.60₹36.10₹11.00

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,381.80₹2,425.40₹2,451.30₹2,429.60
Current Assets₹50.90₹484.20₹540.60₹578.80
Total Assets₹2,432.70₹2,909.60₹2,991.90₹3,008.40
Current Liabilities₹56.70₹310.30₹315.40₹361.20
Net Current Asset-₹5.80₹173.90₹225.20₹217.60
Non-Current Liabilities₹63.70₹281.20₹302.00₹232.70
Equity Capital₹2,312.30₹2,318.10₹2,374.50₹2,414.50
Total Equity & Liabilities₹2,432.70₹2,909.60₹2,991.90₹3,008.40
* All values are in INR Crore
Jubilant Pharmova market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Jubilant Pharmova technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
38.81
Neutral
ATR (14)
30.71
Neutral
STOCH(9,6)
40.54
Neutral
STOCH RSI (14)
14.58
Bullish
ADX(9)
24.04
Bearish
UO(9)
58.44
Neutral
ROC(12)
-1.98
Bearish
WillR(14)
-61.63
Neutral
Period
Simple value
Exponential vaue
5D
942.1
937.77
10D
938.48
941.75
20D
948.21
952.59
50D
962.3
961.49
100D
962.03
956.07
Volume trend — traded volume by day
2 Nov1L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct1L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Jubilant Pharmova
Pharmaceuticals
Add Stock
Add Another

Jubilant Pharmova Returns Calculator

Ex-date: 24 Jul 2026

Jubilant Pharmova Latest News

1 month ago
NIFTY50 tanks nearly 6% in September, but these NIFTY 500 stocks rallied up to 20%; check the outliers list
1 month ago
Finolex Cables, Wockhardt, Paytm: Top five Nifty500 stocks that outperformed index this week; check list
Showing news item 1 of 2

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

Jubilant Pharmova Share Price FAQs

Please be aware that Jubilant Pharmova stock prices are subject to continuous fluctuations due to various factors.